Professor Christian Perronne Interview – Part 4
In this 4th and last part of our landmark interview with Professor Christian Perronne, we touch upon the following topics: The politicization of medicine Why
In this 4th and last part of our landmark interview with Professor Christian Perronne, we touch upon the following topics: The politicization of medicine Why
Today, Facebook took down the discussion group of COVEXIT, which had nearly 4,000 members. The usual explanation was given – a breach of community standards.
This Wednesday June 24, Dr Didier Raoult, the esteemed professor of infectious diseases at the IHU-Marseille, presented a shock testimony at a special commission, in
The much anticipated research on 3,737 COVID-19 patients by Professor Raoult and his team was published this June 25th, as a pre-proof, in the journal
Professor Perronne’s book “Is there a mistake they did not do? COVID-19: the sacred union of incompetence and arrogance” continues to make waves in France,
These are notes relating to a video of a recent TV programme in Brazil about COVID-19 and hydroxychloroquine-based treatments. They were put together by a
“This is your Darkest Hour, Boris: let’s have some real leadership. Without that, God help us all.” While the #OxfordGate #RecoveryGate #CovidPapers story is still
“Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result,” said Peter Horby, Professor of Emerging Infectious
Little noticed was an announcement on May 27 by the Oxford RECOVERY trial that Remdesivir was now available for those participating in the trial, encompassing
While the hydroxychloroquine arm of the RECOVERY Randomized Clinical Trial was terminated last Friday, the research continues to make waves in the French media, seemingly
In a video interview today, Professor Didier Raoult, from IHU-Marseille, blasts the Oxford academics having carried out the RECOVERY randomized controlled trials having tested hydroxychloroquine
Here is a dive into the study on “post-exposure prophylaxis” for COVID-19, recently published in the New England Journal of Medicine. The present article challenges